Autophagy is a catabolic process for recycling of cellular contents in response to metabolic stress in malignant
tumors. We explored efficacy of the synthetic
retinoid N-(4-hydroxyphenyl)
retinamide (4-HPR) and the isoflavonoid
apigenin (APG) in the serum-starved human malignant
neuroblastoma cells. Combination of 0.5 μM
4-HPR and 50 μM APG synergistically decreased cell viability in the serum-starved
neuroblastoma SH-SY5Y, SK-N-BE2, and IMR-32 cells.
Acridine orange (AO) staining and LC3 II upregulation showed that serum-
starvation for 12 and 24h progressively increased the formation of acidic vesicular organelles (AVO) and autophagy in SH-SY5Y cells. Further, AO staining and flow cytometry showed blockage of formation of AVO and accumulation of auophagic population, respectively, following the treatment of the serum-starved SH-SY5Y cells with combination of 0.5 μM
4-HPR and 50 μM APG. Combination
therapy downregulated autophagy inducing
proteins such as
Beclin 1, LC3 II, TLR-4, and Myd88 while upregulated autophagy inhibitory p-Akt/mTOR singaling pathway. Consistent with the hypothesis that inhibition of autophagy could induce apoptosis, we noticed inhibition of autophagy and induction of apoptosis in the serum-starved SH-SY5Y cells with the suppression of the survival factor NF-κB, upregulation of pro-apoptotic Bax, downregulation of anti-apoptotic Bcl-2, activation of
caspase-3, and degradation of
poly(ADP-ribose) polymerase (PARP) after combination
therapy. Collectively, combination of
4-HPR and APG worked synergistically to suppress autophagy and promote apoptosis in human malignant
neuroblastoma cells.